Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.
A plain language summary from pembrolizumab plus ipilimumab following PD-1 antibody failure in melanoma
A new plain language summary discussing the results of a clinical study that looked at the use of two immunotherapy drugs, pembrolizumab and ipilimumab, for the treatment of advanced melanoma.
